What is the official website of Eye Care ?

The official website of Eye Care is https://www.abbvie.com/science/areas-of-focus/eye-care.html.

What is Eye Care's cybersecurity risk score?

Eye Care has an AI-generated cybersecurity risk score of 753 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Eye Care experienced?

According to Rankiteo, Eye Care currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Eye Care been affected by any supply chain cyber incidents ?

According to Rankiteo, Eye Care has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Eye Care have SOC 2 Type 1 certification ?

According to Rankiteo, Eye Care is not certified under SOC 2 Type 1.

Does Eye Care have SOC 2 Type 2 certification ?

According to Rankiteo, Eye Care does not hold a SOC 2 Type 2 certification.

Does Eye Care comply with GDPR ?

According to Rankiteo, Eye Care is not listed as GDPR compliant.

Does Eye Care have PCI DSS certification ?

According to Rankiteo, Eye Care does not currently maintain PCI DSS compliance.

Does Eye Care comply with HIPAA ?

According to Rankiteo, Eye Care is not compliant with HIPAA regulations.

Does Eye Care have ISO 27001 certification ?

According to Rankiteo,Eye Care is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Eye Care operate in ?

Eye Care operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Eye Care have ?

Eye Care employs approximately 0 people worldwide.

Does Eye Care own any subsidiaries ?

Eye Care presently has no subsidiaries across any sectors.

How many LinkedIn followers does Eye Care have ?

Eye Care's official LinkedIn profile has approximately 437 followers.

What is the NAICS classification code for Eye Care ?

Eye Care is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Eye Care have a Crunchbase profile ?

No, Eye Care does not have a profile on Crunchbase.

Does Eye Care have a LinkedIn profile ?

Yes, Eye Care maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/abbvie-eye-care.

How many cybersecurity incidents has Eye Care experienced ?

As of September 23, 2026, Rankiteo reports that Eye Care has experienced 2 cybersecurity incidents.

How many peer or competitor companies does Eye Care have ?

Eye Care has an estimated 5,769 peer or competitor companies worldwide.

What types of cybersecurity incidents has Eye Care faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach and Vulnerability.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Eye Care

Boost Score +25 with badge (5 left)

753

/1000

Fair

778

/1000

Fair

Eye Care Vendor Cyber Rating & Cyber Score

abbvie.com

Add Your Compliance Badge

Follow AbbVie’s Eye Care page for news and updates about our commitment to help people living with retina-related diseases, glaucoma, dry eye disease and refractive conditions. Our goal is to preserve and protect vision, with patients at the heart of everything we do.

Eye Care

Eye Care CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

AbbVie

Vulnerability

100

4/2026

EGAABB177565877...

Eye Care

Breach

100

6/2023

ABB0473723

Loading…

A.I.

Eye Care Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Eye Care

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Eye Care in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Eye Care in 2026.

Incident Types Eye Care vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Eye Care in 2026.

Incident History - Eye Care (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Eye Care Subsidiaries

Eye Care

Pharmaceutical Manufacturing

Website: https://www.abbvie.com/science/areas-of-focus/eye-care.html

Company Size: 0

AbbViePharmaceutical Manufacturing

AbbVieEyetoEyePharmaceutical Manufacturing

Allergan AestheticsPharmaceutical Manufacturing

CoolSculptingMedical Equipment Manufacturing

BOTOX® Cosmetic (onabotulinumtoxinA)Pharmaceutical Manufacturing

Allergan Medical InstitutePharmaceutical Manufacturing

Allergan Aesthetics Plastic and Regenerative Medicine PortfolioMedical Equipment Manufacturing

Natrelle Breast ImplantsPharmaceutical Manufacturing

JUVÉDERM® Collection of FillersPharmaceutical Manufacturing

Pharmacyclics, an AbbVie CompanyPharmaceutical Manufacturing

OncologyPharmaceutical Manufacturing

ImmunologyPharmaceutical Manufacturing

Loading…

Eye Care Similar Companies

Torrent Pharmaceuticals Ltd

cb torrentpharma.com

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”

Alkem Laboratories Ltd.

alkemlabs.com

A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did! Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of India’s largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries 32% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged. We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries. Another feather in our cap was added on December 23rd, 2015, when, Alkem completed it's Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. Although passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 global R&D centers, we are empowering innovations that align with our philosophy of ‘Extended Lifecare Beyond Boundaries’.

AUROBINDO PHARMA LTD

aurobindo.com

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.

Bristol Myers Squibb

cb bms.com

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

Novartis

novartis.com

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

Johnson & Johnson Innovative Medicine

jnj.com

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. https://bit.ly/3reuMvK

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

SUN PHARMA

sunpharma.com

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe, and a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 3,000 scientists and R&D investments of over 6-8% of annual revenues. At Sun, our people are our greatest asset. Ours has never been a story of individual brilliance but of cultivating a culture of realising collective potential. In our journey, everyone is enabled to take charge in an environment that offers limitless growth opportunities. We are with you every step of the way, so you can shine for years to come. With the launch of our Employee Value Proposition (EVP), we define our promise to ‘Create Your Own Sunshine'—driven by the three pillars of Better Every Day, Take Charge, and Thrive Together. These pillars drive progress at Sun so that people can achieve what they would have thought impossible. Learn more about our EVP here: https://sunpharma.com/careers/

Loading…

NEWS

Eye Care CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

October 29, 2025 07:06 PM

Stakeholders discuss initiatives to achieve USD 1 trillion vision

Lucknow: To fast-track infrastructure and industrial growth in the state, Invest UP, in collaboration with NITI Aayog and key state...

Read Article

October 28, 2025 04:07 PM

Google probes exploitation of critical Windows service CVE

Researchers have traced the threat activity to a newly identified hacker, while separate evidence points to more than one variant.

Read Article

October 26, 2025 07:00 AM

Healthcare Data Breach Statistics

The HIPAA Journal has compiled healthcare data breach statistics from October 2009, when the Department of Health and Human Services (HHS)...

Read Article

October 22, 2025 01:13 PM

Oregon Eye Care Provider and New York Children’s Center Announce Hacking Incidents

Cyberattacks have recently been announced by River City Eye in Oregon and Elmcrest Children's Center in New York. River City Eye Care River...

Read Article

October 21, 2025 12:26 AM

River City Eye Care Data Breach Lawsuit Investigation

If you were affected by the River City Eye Care data breach, you may be entitled to compensation.

Read Article

September 30, 2025 06:12 PM

What You’ve Always Wanted to Know About Data Security but Were Afraid to Ask

As an IT professional, you're likely concerned about cybersecurity and the implications of a ransomware attack…and for good reason.

Read Article

September 20, 2025 07:00 AM

Zenni Optical Hosts Expert Panel Following the Launch of EyeQLenz With Zenni ID Guard

NOVATO, Calif.—Zenni Optical announced it convened a panel this week called “Protect Your Eyes, Your Choice, Your Way,” bringing together...

Read Article

September 18, 2025 01:55 AM

Florida patients at risk after major data breach at eye care provider

A significant data breach at Retina Group of Florida has compromised the personal and medical information of nearly 153000 patients.

Read Article

September 17, 2025 07:00 AM

The VA eyes ‘aggressive deployment’ of AI; More than 100 cybersecurity experts urge senators to confirm Pentagon CIO

Lawmakers pressed Charles Worthington on data privacy and workforce readiness as the VA pushes ahead with AI.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-95828

SUMMARY

A vulnerability was determined in Mstfakts College-Management-System. This affects the function session_start of the file Front-end/server.php of the component Authentication. Executing a manipulation can lead to session fixiation. It is possible to launch the attack remotely. The exploit has been publicly disclosed and may be utilized. This product takes the approach of rolling releases to provide continious delivery. Therefore, version details for affected and updated releases are not available. The project was informed of the problem early through an issue report but has not responded yet.

Published

Date2026-09-22

Updated

Date2026-09-22

RISK INFORMATION (Score: 4.3)

cvss2

Base Score: 5.0

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:N/A:N

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:N/A:N

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.8

REFERENCES

CVE-2026-95820

SUMMARY

A vulnerability was found in anirbandutta9 College-Notes-Gallery up to 8c1cf3d98f30982d069c88ca172612c001eb39f6. Affected by this issue is some unknown functionality of the file /dashboard/userprofile.php?section=admin1. Performing a manipulation of the argument image results in unrestricted upload. It is possible to initiate the attack remotely. The exploit has been made public and could be used. This product is using a rolling release to provide continious delivery. Therefore, no version details for affected nor updated releases are available. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-22

Updated

Date2026-09-22

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-61685

SUMMARY

ReactPress is a publishing system for React developers. Prior to version 3.7.0, ReactPress API list endpoints build TypeORM `QueryBuilder` conditions using unsanitized HTTP query parameter names as SQL column identifiers (e.g. `` `article.${key}` ``). TypeORM parameterizes values but not column names, allowing unauthenticated attackers to inject SQL through crafted query string keys. Version 3.7.0 contains a patch. As a workaround, allowlist allowed filter column names before interpolating into SQL.

Published

Date2026-09-22

Updated

Date2026-09-22

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Impact Score

3.6

Exploitability

3.9

REFERENCES

CVE-2026-57576

SUMMARY

plone.app.dexterity is a content-type system for the Plone content management system, and plone.app.contenttypes provides Plone’s Dexterity-based content types. Plone.app.dexterity versions through 3.2.2, 4.0.0 through 4.1.2, and 5.0.0, and plone.app.contenttypes versions through 3.0.11, 4.0.0 through 4.0.9, and 5.0.0 are vulnerable to denial of service because an authenticated user can create content with excessively long titles, descriptions, or uploaded-file names, causing Plone to become unresponsive and potentially making the resulting content difficult to edit or delete. The vulnerability is patched in plone.app.dexterity versions 3.2.3, 4.1.3, and 5.0.1, and in plone.app.contenttypes versions 3.0.12, 4.0.10, and 5.0.1.

Published

Date2026-09-22

Updated

Date2026-09-22

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

2.8

REFERENCES

CVE-2026-18176

SUMMARY

IBM Financial Transaction Manager (FTM) for RedHat OpenShift could allow a remote attacker to obtain sensitive information due to cleartext transmission of sensitive information.

Published

Date2026-09-22

Updated

Date2026-09-22

RISK INFORMATION (Score: 7.4)

cvss3

Base Score: 7.4

Complexity: LOW

CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:C/C:H/I:N/A:N

Impact Score

Exploitability

2.8

REFERENCES

https://www.ibm.com/support/pages/node/7288641

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Eye Care Vendor Cyber Rating & Cyber Score

Eye Care A.I CyberSecurity Scoring

Eye Care CyberSecurity News & History

Eye Care Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Eye Care

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Eye Care vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Eye Care (X = Date, Y = Severity)

Eye Care Subsidiaries

Eye Care

Eye Care Similar Companies

Torrent Pharmaceuticals Ltd

Alkem Laboratories Ltd.

AUROBINDO PHARMA LTD

Bristol Myers Squibb

Takeda

Novartis

Johnson & Johnson Innovative Medicine

Teva Pharmaceuticals

SUN PHARMA

Eye Care CyberSecurity News

Stakeholders discuss initiatives to achieve USD 1 trillion vision

Google probes exploitation of critical Windows service CVE

Healthcare Data Breach Statistics

Oregon Eye Care Provider and New York Children’s Center Announce Hacking Incidents

River City Eye Care Data Breach Lawsuit Investigation

What You’ve Always Wanted to Know About Data Security but Were Afraid to Ask

Zenni Optical Hosts Expert Panel Following the Launch of EyeQLenz With Zenni ID Guard

Florida patients at risk after major data breach at eye care provider

The VA eyes ‘aggressive deployment’ of AI; More than 100 cybersecurity experts urge senators to confirm Pentagon CIO

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Eye Care CyberSecurity News & History

Eye Care Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Eye Care

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Eye Care vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Eye Care (X = Date, Y = Severity)

Eye Care Subsidiaries

Eye Care

Eye Care Similar Companies

Torrent Pharmaceuticals Ltd

Alkem Laboratories Ltd.

AUROBINDO PHARMA LTD

Bristol Myers Squibb

Takeda

Novartis

Johnson & Johnson Innovative Medicine

Teva Pharmaceuticals

SUN PHARMA

Eye Care CyberSecurity News

Stakeholders discuss initiatives to achieve USD 1 trillion vision

Google probes exploitation of critical Windows service CVE

Healthcare Data Breach Statistics

Oregon Eye Care Provider and New York Children’s Center Announce Hacking Incidents

River City Eye Care Data Breach Lawsuit Investigation

What You’ve Always Wanted to Know About Data Security but Were Afraid to Ask

Zenni Optical Hosts Expert Panel Following the Launch of EyeQLenz With Zenni ID Guard

Florida patients at risk after major data breach at eye care provider

The VA eyes ‘aggressive deployment’ of AI; More than 100 cybersecurity experts urge senators to confirm Pentagon CIO

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo